Masako Nakano

Robust Central Reduction of Amyloid-β in Humans with an Orally Available, Non-Peptidic β-Secretase Inhibitor

Patrick C. May, Robert A. Dean, Stephen L. Lowe et al. · Journal of Neuroscience · 2011 · 369 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Mesenchymal stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes

Kanna Nagaishi, Yuka Mizue, Takako Chikenji et al. · Scientific Reports · 2016 · 269 citations · Full text

Medicine, Cell Biology, Pathobiology +17

Bone marrow-derived mesenchymal stem cells improve cognitive impairment in an Alzheimer’s disease model by increasing the expression of microRNA-146a in hippocampus

Masako Nakano, Kenta Kubota, Eiji Kobayashi et al. · Scientific Reports · 2020 · 226 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Bone marrow-derived mesenchymal stem cells improve diabetes-induced cognitive impairment by exosome transfer into damaged neurons and astrocytes

Masako Nakano, Kanna Nagaishi, Naoto Konari et al. · Scientific Reports · 2016 · 211 citations · Full text

Medicine, Neurobiology, Neuroscience +17

Exercise enhances skeletal muscle regeneration by promoting senescence in fibro-adipogenic progenitors

Yuki Saito, Takako Chikenji, Takashi Matsumura et al. · Nature Communications · 2020 · 185 citations · Full text

Medicine, Physiology, Rehabilitation Medicine +16